Abstract
We have carried out a study of large malignant skin tumors (squamous cell carcinomas) and other lesions in hairless mice (groups of 38-45) intermittently exposed to ultraviolet light over a period of 15 weeks, beginning when the mice were about 10 weeks old. The several groups were given a standard diet with 0%, 0.3%, 5%, and 10% added L-ascorbic acid (vitamin C) throughout the study. No lesions developed in unirradiated control groups. The lesions were counted every 14 days for 4 months, beginning 4 weeks before the end of the period of irradiation. The observed incidence of lesions of several sizes during successive time periods was analyzed by the statistical method recommended by a committee of the International Agency for Research on Cancer. A pronounced effect of vitamin C in decreasing the incidence and delaying the onset of the malignant lesions was observed with high statistical significance.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Black H. S., Chan J. T. Suppression of ultraviolet light-induced tumor formation by dietary antioxidants. J Invest Dermatol. 1975 Oct;65(4):412–414. doi: 10.1111/1523-1747.ep12607661. [DOI] [PubMed] [Google Scholar]
- Black H. S., Douglas D. R. Formation of a carcinogen of natural origin in the etiology of ultraviolet light-induced carcinogenesis. Cancer Res. 1973 Sep;33(9):2094–2096. [PubMed] [Google Scholar]
- Black H. S., Lo W. B. Formation of a carcinogen in human skin irradiated with ultraviolet light. Nature. 1971 Dec 3;234(5327):306–308. doi: 10.1038/234306a0. [DOI] [PubMed] [Google Scholar]
- Cameron E., Campbell A., Jack T. The orthomolecular treatment of cancer. III. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy. Chem Biol Interact. 1975 Nov;11(5):387–393. doi: 10.1016/0009-2797(75)90007-1. [DOI] [PubMed] [Google Scholar]
- Cameron E., Campbell A. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact. 1974 Oct;9(4):285–315. doi: 10.1016/0009-2797(74)90019-2. [DOI] [PubMed] [Google Scholar]
- Cameron E., Pauling L. Ascorbic acid and the glycosaminoglycans. An orthomolecular approach to cancer and other diseases. Oncology. 1973;27(2):181–192. doi: 10.1159/000224733. [DOI] [PubMed] [Google Scholar]
- Cameron E., Pauling L., Leibovitz B. Ascorbic acid and cancer: a review. Cancer Res. 1979 Mar;39(3):663–681. [PubMed] [Google Scholar]
- Cameron E., Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3685–3689. doi: 10.1073/pnas.73.10.3685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cameron E., Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4538–4542. doi: 10.1073/pnas.75.9.4538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cameron E., Pauling L. The orthomolecular treatment of cancer. I. The role of ascorbic acid in host resistance. Chem Biol Interact. 1974 Oct;9(4):273–283. doi: 10.1016/0009-2797(74)90018-0. [DOI] [PubMed] [Google Scholar]
- Pauling L., Willoughby R., Reynolds R., Blaisdell B. E., Lawson S. Incidence of squamous cell carcinoma in hairless mice irradiated with ultraviolet light in relation to intake of ascorbic acid (vitamin C) and of D, L-alpha-tocopheryl acetate (vitamin E). Int J Vitam Nutr Res Suppl. 1982;23:53–82. [PubMed] [Google Scholar]